BioNexus Gene Lab (BGLC) Non-cash Items (2022 - 2024)

BioNexus Gene Lab has reported Non-cash Items for 3 years, with the latest figure at -$508330.0 in Q4 2024.

• Quarterly Non-cash Items rose 36.06% year-over-year to -$508330.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$2.3 million (down 21.1% YoY) and the FY2024 annual result came in at -$2.3 million, down 21.1% from the prior year.
• Non-cash Items advanced to -$508330.0 in Q4 2024 per BGLC's latest filing, from -$1.5 million in the prior quarter.
• Over five years, Non-cash Items peaked at $40263.0 in Q1 2022 and troughed at -$1.5 million in Q3 2024.
• A 3-year average of -$391636.8 and a median of -$88513.0 in 2023 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2023 and 2024: Non-cash Items plunged 44889.89% in 2023, then surged 56.66% in 2024.
• Over 3 years, Non-cash Items stood at $2246.0 in 2022, then slumped by 35494.88% to -$794969.0 in 2023, then soared by 36.06% to -$508330.0 in 2024.
• According to Business Quant data, Non-cash Items over the past three periods registered -$508330.0, -$1.5 million, and -$344207.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.